HL7 Terminology (THO)
4.0.0 - Publication
HL7 Terminology (THO)
4.0.0 - Publication
This page is part of the HL7 Terminology (v4.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions 
| Official URL: http://terminology.hl7.org/ValueSet/v2-0227 | Version: 2.0.0 | |||
| Active as of 2019-12-01 | Responsible: HL7, Inc | Computable Name: PHVSManufacturersOfVaccinesMVXCDCNIP | ||
| Other Identifiers: : urn:oid:2.16.840.1.114222.4.11.826 | ||||
Copyright/Legal: Copyright HL7. Licensed under creative commons public domain |
||||
Value Set of codes that specify the organization that manufactures a vaccine. The values are maintained by the US Centers of Disease Control. Note that the source of truth for these code values are maintained by the CDC, and the code system may be acce
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v2-0227
This value set contains 55 concepts
Expansion based on code system fragment PH_ManufacturersOfVaccinesMVX_CDC_NIP v2.ext.0 (CodeSystem)
Expansion based on PH_ManufacturersOfVaccinesMVX_CDC_NIP v2.ext.0 (CodeSystem)
| Code | System | Display | Definition |
| AB | http://terminology.hl7.org/CodeSystem/v2-0227 | Abbott Laboratories | Abbott Laboratories |
| AD | http://terminology.hl7.org/CodeSystem/v2-0227 | Adams Laboratories, Inc. | Adams Laboratories, Inc. |
| ALP | http://terminology.hl7.org/CodeSystem/v2-0227 | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation |
| AR | http://terminology.hl7.org/CodeSystem/v2-0227 | Armour | Armour |
| AVB | http://terminology.hl7.org/CodeSystem/v2-0227 | Aventis Behring L.L.C. | Aventis Behring L.L.C. |
| AVI | http://terminology.hl7.org/CodeSystem/v2-0227 | Aviron | Aviron |
| BA | http://terminology.hl7.org/CodeSystem/v2-0227 | Baxter Healthcare Corporation | Baxter Healthcare Corporation |
| BAH | http://terminology.hl7.org/CodeSystem/v2-0227 | Baxter Healthcare Corporation | Baxter Healthcare Corporation |
| BAY | http://terminology.hl7.org/CodeSystem/v2-0227 | Bayer Corporation | Bayer Corporation |
| BP | http://terminology.hl7.org/CodeSystem/v2-0227 | Berna Products | Berna Products |
| BPC | http://terminology.hl7.org/CodeSystem/v2-0227 | Berna Products Corporation | Berna Products Corporation |
| MIP | http://terminology.hl7.org/CodeSystem/v2-0227 | Bioport Corporation | Bioport Corporation |
| CNJ | http://terminology.hl7.org/CodeSystem/v2-0227 | Cangene Corporation | Cangene Corporation |
| CMP | http://terminology.hl7.org/CodeSystem/v2-0227 | Celltech Medeva Pharmaceuticals | Celltech Medeva Pharmaceuticals |
| CEN | http://terminology.hl7.org/CodeSystem/v2-0227 | Centeon L.L.C. | Centeon L.L.C. |
| CHI | http://terminology.hl7.org/CodeSystem/v2-0227 | Chiron Corporation | Chiron Corporation |
| CON | http://terminology.hl7.org/CodeSystem/v2-0227 | Connaught | Connaught |
| DVC | http://terminology.hl7.org/CodeSystem/v2-0227 | DynPort Vaccine Company, LLC | DynPort Vaccine Company, LLC |
| EVN | http://terminology.hl7.org/CodeSystem/v2-0227 | Evans Medical Limited | Evans Medical Limited |
| GEO | http://terminology.hl7.org/CodeSystem/v2-0227 | GeoVax Labs, Inc. | GeoVax Labs, Inc. |
| SKB | http://terminology.hl7.org/CodeSystem/v2-0227 | GlaxoSmithKline | GlaxoSmithKline |
| GRE | http://terminology.hl7.org/CodeSystem/v2-0227 | Greer Laboratories, Inc. | Greer Laboratories, Inc. |
| IAG | http://terminology.hl7.org/CodeSystem/v2-0227 | Immuno International AG | Immuno International AG |
| IUS | http://terminology.hl7.org/CodeSystem/v2-0227 | Immuno-U.S., Inc. | Immuno-U.S., Inc. |
| KGC | http://terminology.hl7.org/CodeSystem/v2-0227 | Korea Green Cross Corporation | Korea Green Cross Corporation |
| LED | http://terminology.hl7.org/CodeSystem/v2-0227 | Lederle | Lederle |
| MBL | http://terminology.hl7.org/CodeSystem/v2-0227 | Massachusetts Biologic Laboratories | Massachusetts Biologic Laboratories |
| MA | http://terminology.hl7.org/CodeSystem/v2-0227 | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories |
| MED | http://terminology.hl7.org/CodeSystem/v2-0227 | MedImmune, Inc. | MedImmune, Inc. |
| MSD | http://terminology.hl7.org/CodeSystem/v2-0227 | Merck & Co., Inc. | Merck & Co., Inc. |
| IM | http://terminology.hl7.org/CodeSystem/v2-0227 | Merieux | Merieux |
| MIL | http://terminology.hl7.org/CodeSystem/v2-0227 | Miles | Miles |
| NAB | http://terminology.hl7.org/CodeSystem/v2-0227 | NABI | NABI |
| NYB | http://terminology.hl7.org/CodeSystem/v2-0227 | New York Blood Center | New York Blood Center |
| NAV | http://terminology.hl7.org/CodeSystem/v2-0227 | North American Vaccine, Inc. | North American Vaccine, Inc. |
| NOV | http://terminology.hl7.org/CodeSystem/v2-0227 | Novartis Pharmaceutical Corporation | Novartis Pharmaceutical Corporation |
| NVX | http://terminology.hl7.org/CodeSystem/v2-0227 | Novavax, Inc. | Novavax, Inc. |
| OTC | http://terminology.hl7.org/CodeSystem/v2-0227 | Organon Teknika Corporation | Organon Teknika Corporation |
| ORT | http://terminology.hl7.org/CodeSystem/v2-0227 | Ortho-Clinical Diagnostics | Ortho-Clinical Diagnostics |
| PD | http://terminology.hl7.org/CodeSystem/v2-0227 | Parkedale Pharmaceuticals | Parkedale Pharmaceuticals |
| PWJ | http://terminology.hl7.org/CodeSystem/v2-0227 | PowderJect Pharmaceuticals | PowderJect Pharmaceuticals |
| PRX | http://terminology.hl7.org/CodeSystem/v2-0227 | Praxis Biologics | Praxis Biologics |
| PMC | http://terminology.hl7.org/CodeSystem/v2-0227 | sanofi pasteur | sanofi pasteur |
| JPN | http://terminology.hl7.org/CodeSystem/v2-0227 | The Research Foundation for Microbial Diseases of Osaka University | The Research Foundation for Microbial Diseases of Osaka University |
| SCL | http://terminology.hl7.org/CodeSystem/v2-0227 | Sclavo, Inc. | Sclavo, Inc. |
| SOL | http://terminology.hl7.org/CodeSystem/v2-0227 | Solvay Pharmaceuticals | Solvay Pharmaceuticals |
| SI | http://terminology.hl7.org/CodeSystem/v2-0227 | Swiss Serum and Vaccine Inst. | Swiss Serum and Vaccine Inst. |
| TAL | http://terminology.hl7.org/CodeSystem/v2-0227 | Talecris Biotherapeutics | Talecris Biotherapeutics |
| USA | http://terminology.hl7.org/CodeSystem/v2-0227 | United States Army Medical Research and Material Command | United States Army Medical Research and Material Command |
| VXG | http://terminology.hl7.org/CodeSystem/v2-0227 | VaxGen | VaxGen |
| WA | http://terminology.hl7.org/CodeSystem/v2-0227 | Wyeth-Ayerst | Wyeth-Ayerst |
| WAL | http://terminology.hl7.org/CodeSystem/v2-0227 | Wyeth-Ayerst | Wyeth-Ayerst |
| ZLB | http://terminology.hl7.org/CodeSystem/v2-0227 | ZLB Behring | ZLB Behring |
| OTH | http://terminology.hl7.org/CodeSystem/v2-0227 | Other manufacturer | Other manufacturer |
| UNK | http://terminology.hl7.org/CodeSystem/v2-0227 | Unknown manufacturer | Unknown manufacturer |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
History
| Date | Action | Custodian | Author | Comment |
| 2020-05-06 | revise | Vocabulary WG | Ted Klein | Migrated to the UTG maintenance environment and publishing tooling. |
IG © 2020+ HL7 International - Vocabulary Work Group. Package hl7.terminology#4.0.0 based on FHIR 4.0.1. Generated 2022-09-14
Links: Table of Contents |
QA Report
| Version History |
Propose a change